The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core (Q34061794)

30 July 2017

title

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core (English)

1 reference

Alzheimer's Disease Neuroimaging Initiative

30 July 2017

main subject

0 references

0 references

1 reference

positron emission tomography

1 reference

based on heuristic

inferred from title

author

Alzheimer's Disease Neuroimaging Initiative

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

30 July 2017

Kewei Chen

0 references

Eric M Reiman

1 reference

30 July 2017

William J Jagust

1 reference

30 July 2017

Susan M Landau

1 reference

30 July 2017

Dan Bandy

1 reference

30 July 2017

Norman L Foster

1 reference

30 July 2017

Chester A Mathis

1 reference

30 July 2017

Julie C Price

1 reference

30 July 2017

Daniel Skovronsky

1 reference

30 July 2017

Robert A Koeppe

1 reference

30 July 2017

publication date

1 May 2010

1 reference

30 July 2017

published in

Alzheimer's and Dementia

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

221-229

1 reference

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Relationships between biomarkers in aging and dementia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Reducing between scanner differences in multi-center PET studies

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Frequent amyloid deposition without significant cognitive impairment among the elderly

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920531

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20451870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20451870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JALZ.2010.03.003

1 reference

30 July 2017

1 reference

30 July 2017

1 reference